Cambridge Consultants, based in both Cambridges across the Atlantic, is profiling the InJentle syringe it designed along with SCHOTT of Mainz, Germany. The glass syringe has some interesting safety and storage features that may be quite useful for dealing with certain drugs.
InJentle’s unique design, employing a ‘pinch seal’ closure, ensures that the drug is not in contact with the metal needle or the adhesive of the syringe during storage, preventing sensitive drugs from interacting with these potential contaminants. This also has the advantage of creating similar stability test requirements as vials. The needle shield has also been designed with robust tamper-evident closure. This enables physicians or patients to determine easily if the syringe is still unused. InJentle™ also includes the flexibility to include further anti-counterfeiting features in the future, such as RFID tags.
SCHOTT InJentle™ incorporates a needle shield that protects the needle and minimizes the risk from the occurrence of ‘hooks’. Sharper ‘virgin’ needles make the injection less painful for patients. In addition, InJentle™ can be combined with particularly thin needles – potentially up to 32 gauge – which are also siliconised, contributing to improved patient application.
InJentle™ has been designed with a range of additional benefits. For example, the special geometry of the glass barrel does not require the use of any tungsten during the glass forming process, making the syringe completely tungsten-free. Although the syringe has been designed with these special features, it is delivered with standard nests and tubs so that it can be filled on standard filling lines.
Press release from Cambridge Consultants: Introducing the SCHOTT InJentle™ syringe – improved stability for sensitive drugs…
SCHOTT product announcement: New Innovative Staked Needle Syringe SCHOTT InJentle™ – Drug Friendly, Patient Friendly…